Insider Trading March 26, 2026

Oklo Insider Sale: Chief Legal Officer Disposes of $600K in Class A Shares

Murphy sells 10,639 shares while analysts adjust price targets amid reactor progress and capital questions

By Avery Klein OKLO
Oklo Insider Sale: Chief Legal Officer Disposes of $600K in Class A Shares
OKLO

Oklo Inc.'s Chief Legal & Strategy Officer, Goodwin William Carroll Murphy, sold 10,639 shares of Class A common stock on March 25, 2026, for $56.48 per share, netting roughly $600,890. The transaction followed Murphy's exercise of 20,685 restricted stock units the previous day. The company has drawn mixed analyst reactions as it moves forward with reactor approvals, a Meta power agreement and leadership appointments.

Key Points

  • Goodwin William Carroll Murphy sold 10,639 Class A shares on March 25, 2026, at $56.48 per share, totaling about $600,890.
  • Murphy exercised 20,685 restricted stock units on March 24, 2026, which converted into Class A common stock before the sale.
  • Analyst actions include UBS lowering its target to $60 (from $95) citing execution and cost concerns with a Neutral rating; Craig-Hallum cut its target to $71 (from $87) citing capital needs with a Hold rating; William Blair reaffirmed Outperform and noted DOE approval of Oklo’s reactor design, relevant to its 1.2 GW power agreement with Meta by 2034.

Oklo Inc. (NASDAQ: OKLO) disclosed an insider transaction late in March 2026 involving its Chief Legal & Strategy Officer, Goodwin William Carroll Murphy. On March 25, 2026, Murphy disposed of 10,639 shares of Class A common stock at a price of $56.48 per share, for a total of approximately $600,890.

That sale came one day after an internal equity conversion event. On March 24, 2026, Murphy exercised 20,685 restricted stock units (RSUs), which converted into Class A common shares prior to the subsequent disposition.


Beyond the insider activity, several brokerages have revised their valuations and ratings on Oklo in recent coverage. UBS trimmed its price target on Oklo to $60 from $95, citing concerns around execution risk and cost pressures, while retaining a Neutral rating. Craig-Hallum also lowered its target to $71 from $87, citing the company’s capital needs and keeping a Hold rating.

By contrast, William Blair maintained an Outperform rating for Oklo. In its assessment, William Blair pointed to advancement in Oklo’s reactor design, noting the program has received its first approval from the Department of Energy. The firm highlights that approval as a material milestone for Oklo’s broader commercial plans.

This regulatory and technical progress relates directly to Oklo’s contractual commitments in the energy sector. The company has a power agreement with Meta intended to supply 1.2 gigawatts by 2034, a target that depends on progress in reactor development and approvals.

Oklo’s CEO, Jacob DeWitte, has been named to the President’s Council of Advisors on Science and Technology, joining other technology and business leaders on the federal advisory body. The appointment signals a rising profile for the company within technology and energy policy circles.

Additionally, a Bernstein report cited in recent coverage argues that small modular reactors are increasingly important for powering growth in artificial intelligence and hyperscalers because of their ability to deliver steady, carbon-free electricity. That perspective frames some investor interest in Oklo’s technology and long-term market opportunity.

These developments - an insider disposition after an RSU conversion, analyst target reductions citing execution and capital concerns, regulatory progress on reactor design, a major power contract timetable, and a CEO advisory appointment - form the latest public signals from Oklo as it advances its small modular reactor program.

Risks

  • Execution risk and cost pressures highlighted by UBS - impacting project delivery and company financials in the energy and industrial sectors.
  • Capital requirements noted by Craig-Hallum - raising concerns about funding needs that affect Oklo’s ability to meet development and commercialization milestones in the energy sector.
  • Dependence on regulatory and technical approvals for reactor design - relevant to Oklo’s ability to fulfill power contracts and scale small modular reactor deployment, affecting energy and data center customers.

More from Insider Trading

Spyre Therapeutics CFO Disposes $370K in Stock, Exercises Options Same Day as Trial Timelines Accelerate Apr 3, 2026 Fold Holdings CEO completes modest stock sale to cover RSU tax obligations Apr 3, 2026 Spyre Therapeutics CEO Executes $739,912 Stock Sale as Trials Accelerate Apr 3, 2026 Spyre Therapeutics CMO Sells Shares, Exercises Options as Trials Accelerate Apr 3, 2026 Fold CFO Sells Small Stake to Meet Tax Withholding as Company Faces Revenue Shortfall Apr 3, 2026